Shortlist for Biomedical Translation Bridge (BTB) Program

OrthoDx has been formally shortlisted to progress to Stage 2 of the Biomedical Translation Bridge (BTB) Program powered by MTPConnect.


The BTB program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage.